Boyer Financial Services’s Cardiol Therapeutics CRDL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDL
MI
Boyer Financial Services's CRDL Position: Q3 2026 in Review
Boyer Financial Services held its Cardiol Therapeutics (CRDL) position steady in Q3 2026 at 34,100 shares worth $56.6K. The position accounts for 0.05% of the portfolio, ranked #60.
Boyer Financial Services first reported a position in CRDL in Q4 2025 and has held it in 4 quarters since. 58 funds tracked by Wall St. Rank hold CRDL as of Q3 2026.
- Boyer Financial Services held 34,100 shares of Cardiol Therapeutics worth $56.6K as of Q3 2026.
- Boyer Financial Services left its Cardiol Therapeutics share count unchanged in Q3 2026.
- Cardiol Therapeutics made up 0.05% of Boyer Financial Services's portfolio in Q3 2026, its #60 holding.
- Boyer Financial Services first reported a position in Cardiol Therapeutics in Q4 2025 and has held it in 4 quarters since.
- 58 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q3 2026.
Based on Boyer Financial Services's 13F filing for Q3 2026, filed 23 Oct 2026.